Supportive Oncodermatology News: What is the COCOON Regimen, and How Can it Help Lung Cancer Patients?

A structured dermatologic prophylaxis regimen—the COCOON regimen—can halve skin toxicities in patients receiving first-line amivantamab plus lazertinib for epidermal growth factor receptor (EGFR)–mutated advanced non–small-cell lung cancer (NSCLC), finds research in Oncoscience.